Grown Rogue International (GRUSF) EBITDA Margin Growth (5y) (2014 - 2023)
Grown Rogue International (GRUSF) EBITDA Margin Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2023 | 4,558.00 |
| Apr 30, 2023 | 25,053.00 |
| Jan 31, 2023 | 55,812.00 |
| Feb 28, 2015 | 414,098.00 |
| Nov 30, 2014 | 187,905.00 |
| Aug 31, 2014 | 994,532.00 |
| May 31, 2014 | 810,739.00 |
| Feb 28, 2014 | -141,910.00 |